Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer
出版年份 2021 全文链接
标题
Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer
作者
关键词
-
出版物
BREAST CANCER RESEARCH AND TREATMENT
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-04-05
DOI
10.1007/s10549-021-06192-w
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The Role of Speckle Strain Echocardiography in the Diagnosis of Early Subclinical Cardiac Injury in Cancer Patients—Is There More Than Just Left Ventricle Global Longitudinal Strain?
- (2021) Michal Laufer-Perl et al. Journal of Clinical Medicine
- Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial
- (2020) Daniel Eiger et al. BRITISH JOURNAL OF CANCER
- Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a Position Statement and new risk assessment tools from the Cardio‐Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio‐Oncology Society
- (2020) Alexander R. Lyon et al. EUROPEAN JOURNAL OF HEART FAILURE
- The role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a Position statement on behalf of the Heart Failure Association ( HFA ), the European Association of Cardiovascular Imaging ( EACVI ) and the Cardio‐Oncology Council of the European Society of Cardiology ( ESC )
- (2020) Jelena Čelutkienė et al. EUROPEAN JOURNAL OF HEART FAILURE
- Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy
- (2020) Paaladinesh Thavendiranathan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial
- (2019) Helena M Earl et al. LANCET
- HER2 and Breast Cancer — A Phenomenal Success Story
- (2019) Daniel F. Hayes NEW ENGLAND JOURNAL OF MEDICINE
- A pooled analysis of the cardiac events in the trastuzumab adjuvant trials
- (2019) Evandro de Azambuja et al. BREAST CANCER RESEARCH AND TREATMENT
- Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients
- (2018) Mariana L. Henry et al. JACC-Cardiovascular Imaging
- Comparative Toxicity and Effectiveness of Trastuzumab-Based Chemotherapy Regimens in Older Women With Early-Stage Breast Cancer
- (2017) Katherine E. Reeder-Hayes et al. JOURNAL OF CLINICAL ONCOLOGY
- Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis
- (2016) Charles Guenancia et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer
- (2016) Chau Dang et al. JAMA Oncology
- Duration and Toxicity of Adjuvant Trastuzumab in Older Patients With Early-Stage Breast Cancer: A Population-Based Study
- (2014) Ines Vaz-Luis et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant trastuzumab in elderly with HER-2 positive breast cancer: A systematic review of randomized controlled trials
- (2012) Janaina Brollo et al. CANCER TREATMENT REVIEWS
- Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2012) Edward H. Romond et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
- (2012) E. J. A. Bowles et al. JNCI-Journal of the National Cancer Institute
- Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors
- (2011) C. Serrano et al. ANNALS OF ONCOLOGY
- Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
- (2011) Luigi Tarantini et al. JOURNAL OF CARDIAC FAILURE
- Independent Adjudication of Symptomatic Heart Failure With the Use of Doxorubicin and Cyclophosphamide Followed by Trastuzumab Adjuvant Therapy: A Combined Review of Cardiac Data From the National Surgical Adjuvant Breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 Clinical Trials
- (2010) Stuart D. Russell et al. JOURNAL OF CLINICAL ONCOLOGY
- Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring
- (2009) A L Jones et al. BRITISH JOURNAL OF CANCER
- Cardiotoxicity Profile of Trastuzumab
- (2008) Steven M Ewer et al. DRUG SAFETY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now